LEO Pharma Completes Peplin Inc. Acquisition; Peplin to Continue as an Independent Subsidiary
11/12/2009 11:16:22 AM
More...
|
LEO Pharma to Acquire Peplin Inc. for $287.5 Million
9/3/2009 7:11:30 AM
More...
|
Peplin Inc. Results for the Financial Year Ended 30 June 2009
9/1/2009 9:57:12 AM
More...
|
Peplin Inc. Initiates its Final Phase 3 Clinical Trial for PEP005 Gel in AK
7/23/2009 9:03:10 AM
More...
|
Peplin Inc. Completes Enrolment in its Phase 3 Clinical Trials for PEP005 Gel in AK on the Face and Scalp
7/7/2009 9:09:59 AM
More...
|
Peplin Inc. Announces the Initiation of Phase 3 Clinical Trials for PEP005 Gel in AK on the Face and Scalp
6/9/2009 11:21:40 AM
More...
|
Positive Results for Peplin Inc.'s s First Phase III AK Trial
5/18/2009 12:06:08 PM
More...
|
Peplin Inc. to Participate in BayBio 2009
4/15/2009 11:22:42 AM
More...
|
Peplin Inc.’s Positive Phase IIb AK Trial Result Details
3/6/2009 12:41:07 PM
More...
|
Peplin Inc. Results for the Quarter Ended 31 December 2008
2/18/2009 10:06:53 AM
More...
|
|